Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 813 results for "sanofi country"

Pharma firm Sanofi opposes drug price control order
Business Today India

Pharma firm Sanofi opposes drug price control order

The move of the National Pharmaceutical Pricing Authority, country's drug price regulator, to control the price of commonly used diabetes and heart diseases drugs in a bid to improve affordability has dismayed the pharma industry. "By issuing a ... Business Today India, 1 week ago
Shares of pharma firms tank on NPPA price cap order Financial Express, 1 week ago

Sanofi dengue vaccine shows promise against 3 out of 4 viruses

Sanofi plans to seek approval for the vaccine in the countries worst affected by dengue next year. Photo: Bloomberg Geneva: The most advanced experimental vaccine against dengue protected some children against the disease in a study, though a ...
 Livemint.com2 weeks ago Vaccine firm warns against Pak polio threat  Online News Pakistan1 week ago Sanofi Dengue Vaccine Protects Some Kids From 3 of 4 Viruses  Washington Post2 weeks ago Dengue vaccine available in PH next year  Rappler1 week ago

Sanofi's NDA for Basal Insulin Toujeo accepted for US FDA's review

Toujeo dossier accepted by EMA for EU countries Jul 09, 2014 (M2 EQUITYBITES via COMTEX News Network) -- Healthcare company Sanofi (EURONEXT:SAN)(NYSE:SNY) stated on Tuesday that the US Food and Drug Administration (FDA) has accepted its New Drug ...
 PredictWallStreet2 weeks ago FDA Accepts Sanofi's New Drug Application for Basal Insulin Toujeo Sanofi  Pharmaceutical & Medical Packaging News1 week ago 7/20/14 - Genzyme's Lemtrada Approved in Argentina for Treatment of Multiple Sclerosis  Pharmacy Choice6 days ago FDA accepts Sanofi SA new drug application for Basal Insulin Toujeo(R)  Reuters UK2 weeks ago

Schools Lead Fight Against Diabetes

- New Delhi, Delhi, India PHFI, HRIDAY, IDF and Sanofi's KiDS (Kids and Diabetes in Schools) project achieves first milestone; begins roll out of specially designed School Diabetes Information Pack in Delhi schools for teachers, parents and ...
 AndhraNews.net1 day ago Delhi schools to receive information and training on Type I and II diabetes  Express Pharma2 days ago 15 Delhi schools to receive training on diabetes management  ZeeNews.com2 days ago

Sanofi To Sell Mature Drugs Portfolio

at 6:36 am EST Click Ticker to See live coverage Sanofi SA (ADR) ( SNY ) wishes to divest its portfolio of old drugs whose patents have expired or are due to expire. As per a document circulated by the CGT labor union , the Paris-based ...
 Bidness Etc1 day ago Sanofi mulls sale of portfolio: Report  CNBC1 week ago Sanofi held talks with Abbott, Mylan on mature drugs -document  CNBC1 week ago UPDATE 1-Sanofi held talks with Abbott, Mylan about mature drugs -document  Reuters1 week ago

Health Canada inspection raises concerns about GSK flu vaccine plant

Health Canada has advised pharmaceutical giant GSK it wants to see an action plan for fixing problems at the country's only flu vaccine production facility. GSK was given 30 days in which to lay out a proposal and timeline for resolving the ...
 Globe and Mail3 days ago
Philippine Daily Inquirer

IN BRIEF: Vaccine shows efficacy against dengue fever

SANOFI Pasteur, the vaccines division of Sanofi, announced the detailed results of its first landmark phase III dengue vaccine efficacy study conducted in five countries in Asia. Results show overall efficacy against symptomatic dengue of 56.5 ...
 New Straits Times4 days ago First dengue vaccine out by July next year  Philippine Daily Inquirer1 week ago Dengue vaccine efficacious in phase 3 trial  Orthopedics Today1 week ago Sanofi working to bring dengue under control  Bio Spectrum Asia1 week ago
Financial Express

Price Caps on $915 Million of Drugs Hurt Sanofi: Corporate India

India's widening of price controls to drugs with revenues of about $915 million adds pressure on the local units of global manufacturers to boost sales volumes. The nation where 825 million people live on under $2 per day capped prices of 50 ...
 Bloomberg1 week ago Sanofi and others hit hard by India's price caps on heart and diabetes drugs  FiercePharma1 week ago Prices capped for 108 more medicines; Ranbaxy, Sanofi to take hit  Financial Express1 week ago UPDATE 1-India caps price of 108 more medicines; drugmakers to take hit  Sify1 week ago
International Business Times India

New Vaccine by Sanofi Could Cure Dengue

New vaccine for Dengue on the horizon, as monsoon sets in. (Picture representation) West Point - The U.S. Military Academy/Flickr As monsoon hits many parts of the world this month, dengue patients may have new hope, as French health care company ...
 International Business Times India2 weeks ago Sanofi's dengue vaccine could debut in 2015  Global Health Progress2 weeks ago Dengue vaccine trial shows promise, says Sanofi Pasteur  Asia News Network2 weeks ago Sanofi dengue vaccine promising but questions remain  CNBC2 weeks ago

Sanofi receives FDA acceptance for review of NDA for diabetes drug

Sanofi SA has received the FDA acceptance for review of the new drug application, or NDA, for Toujeo, an investigational basal insulin to treat diabetes. The acceptance of the NDA follows the acceptance of the marketing authorization dossier for ...
 Individual.com1 week ago FDA accepts to review Sanofi's NDA for diabetes drug Toujeo  Pharmaceutical Business Review2 weeks ago FDA Accepts Sanofi's NDA Of Toujeo For Review  Pharmacy Choice2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less